These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 12767466)
61. Update on mitochondrial toxicity: where are we now? Walker UA J HIV Ther; 2003 May; 8(2):32-5. PubMed ID: 12838162 [TBL] [Abstract][Full Text] [Related]
62. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963 [TBL] [Abstract][Full Text] [Related]
63. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Venhoff N; Setzer B; Melkaoui K; Walker UA Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766 [TBL] [Abstract][Full Text] [Related]
64. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. Brinkman K; ter Hofstede HJ; Burger DM; Smeitink JA; Koopmans PP AIDS; 1998 Oct; 12(14):1735-44. PubMed ID: 9792373 [No Abstract] [Full Text] [Related]
65. Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women. López S; Coll O; Durban M; Hernàndez S; Vidal R; Suy A; Morén C; Casademont J; Cardellach F; Mataró D; Miró O; Garrabou G Antivir Ther; 2008; 13(6):833-8. PubMed ID: 18839784 [TBL] [Abstract][Full Text] [Related]
66. Nano-NRTIs: efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity. Vinogradov SV; Poluektova LY; Makarov E; Gerson T; Senanayake MT Antivir Chem Chemother; 2010 Oct; 21(1):1-14. PubMed ID: 21045256 [TBL] [Abstract][Full Text] [Related]
67. NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction? Walker UA; Brinkman K HIV Med; 2001 Jul; 2(3):163-5. PubMed ID: 11737396 [No Abstract] [Full Text] [Related]
68. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467 [TBL] [Abstract][Full Text] [Related]
70. Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence. Orkin C; Llibre JM; Gallien S; Antinori A; Behrens G; Carr A HIV Med; 2018 Jan; 19(1):18-32. PubMed ID: 28737291 [TBL] [Abstract][Full Text] [Related]
71. Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures. Stray KM; Park Y; Babusis D; Callebaut C; Cihlar T; Ray AS; Perron M Antiviral Res; 2017 Apr; 140():116-120. PubMed ID: 28131805 [TBL] [Abstract][Full Text] [Related]
72. Anti-HIV drugs and the mitochondria. Pinti M; Salomoni P; Cossarizza A Biochim Biophys Acta; 2006; 1757(5-6):700-7. PubMed ID: 16782042 [TBL] [Abstract][Full Text] [Related]
73. The antiretroviral 2',3'-dideoxycytidine causes mitochondrial dysfunction in proliferating and differentiated HepaRG human cell cultures. Young CKJ; Wheeler JH; Rahman MM; Young MJ J Biol Chem; 2021; 296():100206. PubMed ID: 33334881 [TBL] [Abstract][Full Text] [Related]
74. Ototoxicity associated with use of nucleoside analog reverse transcriptase inhibitors: a report of 3 possible cases and review of the literature. Simdon J; Watters D; Bartlett S; Connick E Clin Infect Dis; 2001 Jun; 32(11):1623-7. PubMed ID: 11340535 [TBL] [Abstract][Full Text] [Related]
75. Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity? de Mendoza C; Sanchez-Conde M; Ribera E; Domingo P; Soriano V AIDS Rev; 2004; 6(3):169-80. PubMed ID: 15595434 [TBL] [Abstract][Full Text] [Related]